乳腺癌中的骨密度：何时进行干预？ - Suppr

Suppr

超能文献

Bone density in breast cancer: when to intervene?

作者信息

Gralow Julie R

出版信息

J Clin Oncol. 2007 Aug 1;25(22):3194-7. doi: 10.1200/JCO.2007.12.3430. Epub 2007 Jun 18.

DOI:10.1200/JCO.2007.12.3430

PMID:17577014

Abstract

摘要

相似文献

Bone density in breast cancer: when to intervene?乳腺癌中的骨密度：何时进行干预？

J Clin Oncol. 2007 Aug 1;25(22):3194-7. doi: 10.1200/JCO.2007.12.3430. Epub 2007 Jun 18.

Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.唑来膦酸可预防接受激素受体阳性乳腺癌辅助内分泌治疗的绝经前女性发生癌症治疗引起的骨质流失：来自奥地利乳腺癌和结直肠癌研究组的报告

J Clin Oncol. 2007 Mar 1;25(7):820-8. doi: 10.1200/JCO.2005.02.7102. Epub 2006 Dec 11.

Zoledronic acid prevents cancer treatment-induced bone loss.唑来膦酸可预防癌症治疗引起的骨质流失。

Oncology (Williston Park). 2005 Mar;19(3):390.

Women and bone health: maximizing the benefits of aromatase inhibitor therapy.女性与骨骼健康：最大限度地提高芳香化酶抑制剂治疗的获益。

Oncology. 2010;79(1-2):13-26. doi: 10.1159/000314997. Epub 2010 Nov 3.

Aromatase inhibitors and bone health in women with breast cancer.芳香化酶抑制剂与乳腺癌女性的骨骼健康

J Clin Oncol. 2006 Nov 20;24(33):5305-12. doi: 10.1200/JCO.2006.07.5382.

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.绝经前乳腺癌的内分泌治疗加唑来膦酸

N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285.

Bone safety of aromatase inhibitors versus tamoxifen.芳香化酶抑制剂与他莫昔芬的骨骼安全性比较。

Int J Gynecol Cancer. 2006;16 Suppl 2:518-20. doi: 10.1111/j.1525-1438.2006.00685.x.

[Breast carcinoma: new, much promising trends. The cancer anxiety of women -- will be taken better care soon?].[乳腺癌：新的、颇具前景的趋势。女性的癌症焦虑——很快会得到更好的关注吗？]

MMW Fortschr Med. 2005 Mar 10;147(10):4-6.

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up.唑来膦酸用于接受辅助芳香化酶抑制剂治疗的原发性乳腺癌女性骨质疏松症和骨质减少症的治疗：5年随访

Support Care Cancer. 2016 Mar;24(3):1219-26. doi: 10.1007/s00520-015-2915-2. Epub 2015 Aug 23.

The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial.唑来膦酸对接受序贯他莫昔芬和来曲唑治疗的早期乳腺癌绝经后妇女骨丢失的保护作用：一项前瞻性、随机、II 期试验。

Oncology. 2011;81(5-6):298-305. doi: 10.1159/000334456. Epub 2011 Dec 8.

引用本文的文献

Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience.激素受体阳性早期乳腺癌患者对骨骼健康指南的依从性：瑞士队列研究的现状及临床影响

Bone Rep. 2021 Dec 11;16:101160. doi: 10.1016/j.bonr.2021.101160. eCollection 2022 Jun.

Assessment of Breast Cancer Management in Sub-Saharan Africa.撒哈拉以南非洲地区乳腺癌管理评估。

JCO Glob Oncol. 2021 Sep;7:1593-1601. doi: 10.1200/GO.21.00282.

Correlation between bone mineral density and endometrial thickness over time in women with breast cancer history.乳腺癌病史女性的骨密度与子宫内膜厚度随时间的相关性。

Sci Prog. 2021 Jan-Mar;104(1):368504211000515. doi: 10.1177/00368504211000515.

The Bone Phenotype and Pain Response to Pamidronate in Tyrosine Kinase Inhibitor-Treated Chronic Myelogenous Leukemia.酪氨酸激酶抑制剂治疗的慢性粒细胞白血病患者的骨表型及对帕米膦酸的疼痛反应

J Endocr Soc. 2019 Mar 11;3(5):857-864. doi: 10.1210/js.2018-00268. eCollection 2019 May 1.

Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.激素治疗与乳腺癌幸存者的骨质疏松症：风险评估及对筛查建议的依从性。

Osteoporos Int. 2019 Jan;30(1):187-200. doi: 10.1007/s00198-018-4758-4. Epub 2018 Nov 9.

Skeletal and Uterotrophic Effects of Endoxifen in Female Rats.内美通对雌性大鼠骨骼及子宫营养的影响。

Endocrinology. 2017 Oct 1;158(10):3354-3368. doi: 10.1210/en.2016-1871.

Associations of individual characteristics and lifestyle factors with metabolism of di-2-ethylhexyl phthalate in NHANES 2001-2012.2001 - 2012年美国国家健康与营养检查调查（NHANES）中个体特征和生活方式因素与邻苯二甲酸二（2 - 乙基己基）酯代谢的关联

Environ Res. 2016 Aug;149:23-31. doi: 10.1016/j.envres.2016.05.002. Epub 2016 May 9.

Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.唑来膦酸可预防早期乳腺癌绝经前女性在接受辅助化疗时出现骨质流失。

J Clin Oncol. 2008 Oct 10;26(29):4739-45. doi: 10.1200/JCO.2008.16.4707. Epub 2008 Aug 18.

Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial.利塞膦酸盐可预防乳腺癌幸存者的骨质流失：一项为期2年的随机、双盲、安慰剂对照临床试验。

J Clin Oncol. 2008 Jun 1;26(16):2644-52. doi: 10.1200/JCO.2007.15.2967. Epub 2008 Apr 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验